Abbreviations - Raspberry leaf tea
In this guide
In this guide| ADI | Acceptable daily intake | 
| ALP | Alkaline phosphatase | 
| ALT | Alanine aminotransferase | 
| AMMC | 3-[2-(N,N-diethyl-N-methylammonium)ethyl]-7-methoxy-4- methylcoumarin | 
| API | Adiposity percentage | 
| AST | Aspartate transaminase | 
| BFC | 7-benzyloxy-4-(trifluoromethyl)- coumarin | 
| BMI | Body mass index | 
| BQ | 7-benzyloxyquinoline | 
| bw | Body weight | 
| CEC | 3-cyano-7- ethoxycoumarin | 
| CI | Confidence interval | 
| CYP | Cytochrome P450 | 
| DES | Diethylstilbestrol | 
| DMSO | Dimethylsulfoxide | 
| EC50 | Half-maximal effective concentration | 
| EFC | 7-ethoxy-4-trifloromethyl-coumarin | 
| EMA | European Medicines Agency | 
| ERES | Ethoxyresorufin | 
| FSA | Food Standards Agency | 
| GDM | Gestational diabetes mellitus | 
| HBGV | Health-based guidance value | 
| HPLC | High-performance liquid chromatography | 
| IC50 | Half-maximal inhibitory concentration | 
| LCMS/MS | Liquid chromatography mass spectrometry/mass spectrometry | 
| LOQ | Limit of quantification | 
| MFC | 7-methoxy-4-(trifuoromethyl)-coumarin | 
| MHRA | Medicines and Healthcare products Regulatory Agency | 
| MRES | Methoxyresorufin | 
| MRL | Maximum residue level | 
| NDNS | National Diet and Nutrition Survey | 
| NOAEL | No-observed-adverse-effect level | 
| NP | Non-pregnant | 
| RLE | Raspberry leaf extract | 
| RLE-H | High-temperature, high-pressure raspberry leaf extract | 
| RLP | Raspberry leaf powder | 
| SACN | Scientific Advisory Committee on Nutrition | 
| TG2 | Transglutaminase 2 | 
| TDI | Tolerable daily intake | 
| TUL | Tolerable upper intake level | 
| UKTIS | UK Teratology Information Service | 
| WHO | World Health Organization |